Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Localized disease diagnostic type:
6.1 Type 1 Diabetes
6.2 Hashimoto Thyroiditis
Chapter 7 Market Segmentation by Systematic disease diagnostic type:
7.1 Multiple sclerosis
7.2 Systematic lupus erythematosus
7.3 Rheumatoid Arthritis
7.4 Psoriasis
Chapter 8 Market Segmentation by Test type
8.1 Urinalysis
8.2 Total blood count
8.3 Autoantibody test
8.4 C-reactive protein test,
8.5 Erythrocyte sedimentation rate,
Chapter 9 Market Segmentation by End-user type
9.1 Labs and research centres
9.2 Hospitals
Chapter 10 Market Segmentation by geography
10.1 North America
10.1.1 Introduction
10.1.2 United States
10.1.3 Canada
10.1.4 Mexico
10.1.5 Others
10.2 Europe
10.2.1 Introduction
10.2.2 Spain
10.2.3 UK
10.2.4 Russia
10.2.5 France
10.2.6 Italy
10.2.7 Others
10.3 Asia-Pacific
10.3.1 Introduction
10.3.2 India
10.3.3 China
10.3.4 Japan
10.3.5 Others
10.4 The Middle East and Africa
10.4.1 Saudi Arabia
10.4.2 South Africa
10.4.3 Others
Chapter 11 Competitive Landscape
11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
11.2 Market Share Analysis
11.3 Strategies Adopted By Top Companies
Chapter 12 Company Profile
12.1 Beckman Coulter, Inc.
12.1.1 Introduction
12.1.2 Company overview
12.13 Financial Performance
12.14 Product Benchmarking
12.2 SQI Diagnostics, Inc.
12.3 EUROIMMUN AG
12.4 AESKU Diagnostics GmbH & Co. KG
12.5 F. Hoffmann-La Roche Ltd
12.6 Quest Diagnostics
12.7 Abbott Laboratories
12.8 Siemens Healthiness
12.9 Roche Diagnostics
12.10 INOVA Diagnostics Inc.
12.11 Bio Merieux SA
12.12 Crescendo Bioscience Inc.
12.13 Hemagen Diagnostics Inc.
12.14 Bio-Rad Laboratories Inc.
12.15 Orgentec
Chapter 13 Market Estimates and Forecast
13.1 Market Estimation and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Systematic disease diagnostic Type 2018-2024(USD Million)
13.1.2 Market Estimates and Forecast by Localized disease diagnostic Type 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecast by Test type 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecast by End-user type 2018-2024(USD Million)
13.1.5 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
13.1.6 Market Estimates and Forecast by Company 2018-2024(USD Million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Investment Opportunities
14.3 Analyst Opinion
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
